BAMCO Inc
REGN icon

BAMCO Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

BAMCO Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,500
Closed -$4.73M – 336
2024
Q3 		$4.73M Buy
+4,500
New +$5.01M 0.01% 265
2018
Q1 		– Sell
-6,673
Closed -$2.51M – 364
2017
Q4 		$2.51M Hold
6,673
– – 0.01% 269
2017
Q3 		$2.98M Sell
6,673
-388
-5% -$185K 0.01% 255
2017
Q2 		$3.47M Buy
7,061
+632
+10% +$277K 0.02% 245
2017
Q1 		$2.49M Buy
6,429
+1,460
+29% +$541K 0.01% 249
2016
Q4 		$1.82M Buy
4,969
+45
+0.9% +$17.1K 0.01% 255
2016
Q3 		$1.98M Sell
4,924
-63
-1% -$25.3K 0.01% 245
2016
Q2 		$1.74M Sell
4,987
-24
-0.5% -$9.24K 0.01% 246
2016
Q1 		$1.81M Sell
5,011
-2,452
-33% -$1.01M 0.01% 245
2015
Q4 		$4.05M Hold
7,463
– – 0.02% 236
2015
Q3 		$3.47M Sell
7,463
-16
-0.2% -$8.59K 0.02% 259
2015
Q2 		$3.81M Sell
7,479
-11
-0.1% -$5.37K 0.02% 273
2015
Q1 		$3.38M Hold
7,490
– – 0.01% 278
2014
Q4 		$3.07M Buy
7,490
+381
+5% +$150K 0.01% 278
2014
Q3 		$2.56M Hold
7,109
– – 0.01% 285
2014
Q2 		$2.01M Buy
7,109
+1,025
+17% +$304K 0.01% 289
2014
Q1 		$1.83M Buy
+6,084
New +$1.87M 0.01% 291

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc's REGN Position: Q4 2024 in Review

BAMCO Inc sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 4,500 shares — an estimated $4.73M sold.

BAMCO Inc first reported a position in REGN in Q1 2014 and held it in 17 quarters. The position peaked at $4.73M in Q3 2024. 1,320 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • BAMCO Inc reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • BAMCO Inc sold 4,500 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $4.73M.
  • BAMCO Inc first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 17 quarters.
  • BAMCO Inc's Regeneron Pharmaceuticals position peaked at $4.73M in Q3 2024.
  • 1,320 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on BAMCO Inc's 13F filing for Q4 2024, filed 14 Feb 2025.